Novocure
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $174,350 | $167,204 | $158,805 | $154,994 |
Gross Profit | 132,193 | 122,475 | 117,333 | 116,473 |
EBITDA | -34,185 | -26,359 | -36,077 | -34,540 |
EBIT | -40,954 | -30,022 | -39,521 | -37,865 |
Net Income | -24,499 | -37,270 | -40,139 | -34,319 |
Net Change In Cash | 174,350 | 167,204 | 158,805 | 154,994 |
Free Cash Flow | 14,919 | -21,422 | -46,276 | |
Cash | 344,638 | 149,624 | 127,279 | |
Basic Shares | 111,471 | 111,908 | 111,572 | 110,282 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $655,353 | $605,220 | $509,338 | $537,840 |
Gross Profit | 488,474 | 468,039 | 381,058 | 422,973 |
EBITDA | -119,049 | -109,584 | -177,452 | -78,899 |
EBIT | -136,250 | -120,819 | -188,421 | -89,523 |
Net Income | -136,227 | -168,627 | -207,043 | -92,534 |
Net Change In Cash | 655,353 | 605,220 | 509,338 | 537,840 |
Cost of Revenue | -93,678 | |||
Free Cash Flow | -69,224 | -100,429 | 9,430 | |
Cash | 163,767 | 240,821 | 115,326 | |
Basic Shares | 111,471 | 107,834 | 106,391 | 104,660 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.22 |
2025-09-30 | -$0.33 |
2025-06-30 | -$0.36 |
